Glenmark Pharmaceuticals Limited
Amansa Holdings trimmed its stake in Glenmark Pharmaceuticals Limited from 2.22% to 2.04%, selling 4,80,904 shares.
A global research-led pharmaceutical company, Glenmark operates across generics, specialty, and over-the-counter business segments with a presence in more than 80 countries worldwide. The company develops and manufactures pharmaceutical products serving patients across multiple therapeutic areas including oncology, dermatology, and respiratory care. Its distinctive strength lies in combining generic drug manufacturing capabilities with specialty pharmaceutical development and maintaining a robust international distribution network across developed and emerging markets.
Singapore-based India-dedicated equity fund founded in 2006 by Akash Prakash (ex-GIC, ex-Temasek India). Concentrated long-only strategy with ~20 listed positions and a disclosed book value of roughly Rs 17,000 cr across names like GMM Pfaudler, Fortis Healthcare, V-Mart Retail and Eicher Motors. One of the original India-only foreign hedge funds, with ~USD 1 bn+ in assets.